| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.60e-06 | 417 | 54 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.09e-06 | 582 | 54 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.06e-05 | 20 | 54 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.91e-05 | 753 | 54 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.19e-05 | 23 | 54 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | structural constituent of tooth enamel | 1.07e-04 | 6 | 54 | 2 | GO:0030345 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.22e-04 | 560 | 54 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.31e-04 | 566 | 54 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | ankyrin repeat binding | 1.49e-04 | 7 | 54 | 2 | GO:0071532 | |
| GeneOntologyMolecularFunction | hydroxyapatite binding | 1.99e-04 | 8 | 54 | 2 | GO:0046848 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.44e-04 | 55 | 54 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.58e-04 | 140 | 54 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | sodium ion binding | 6.40e-04 | 14 | 54 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 1.07e-03 | 18 | 54 | 2 | GO:1990226 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.63e-03 | 187 | 54 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 1.75e-03 | 23 | 54 | 2 | GO:0030021 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.24e-03 | 26 | 54 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.61e-03 | 739 | 54 | 7 | GO:0003682 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 4.29e-05 | 26 | 55 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 7.35e-05 | 31 | 55 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.56e-04 | 596 | 55 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 5.20e-04 | 13 | 55 | 2 | GO:1990907 | |
| MousePheno | small lower incisors | 5.77e-06 | 11 | 47 | 3 | MP:0030080 | |
| MousePheno | short Tomes' process | 1.11e-05 | 2 | 47 | 2 | MP:0030513 | |
| MousePheno | abnormal molar morphology | 2.50e-05 | 51 | 47 | 4 | MP:0002689 | |
| MousePheno | abnormal Tomes' process morphology | 3.31e-05 | 3 | 47 | 2 | MP:0030512 | |
| MousePheno | absent teeth | 3.90e-05 | 20 | 47 | 3 | MP:0030610 | |
| MousePheno | small incisors | 5.25e-05 | 22 | 47 | 3 | MP:0030079 | |
| MousePheno | large mandible | 6.61e-05 | 4 | 47 | 2 | MP:0030050 | |
| MousePheno | abnormal lower incisor morphology | 7.78e-05 | 25 | 47 | 3 | MP:0030136 | |
| MousePheno | microdontia | 8.77e-05 | 26 | 47 | 3 | MP:0030088 | |
| MousePheno | enamel pits | 1.10e-04 | 5 | 47 | 2 | MP:0030460 | |
| MousePheno | abnormal hair follicle morphology | 1.33e-04 | 148 | 47 | 5 | MP:0000377 | |
| MousePheno | impaired placental function | 1.65e-04 | 6 | 47 | 2 | MP:0006372 | |
| MousePheno | short upper incisors | 1.65e-04 | 6 | 47 | 2 | MP:0030090 | |
| MousePheno | hindlimb oligodactyly | 2.30e-04 | 7 | 47 | 2 | MP:0014281 | |
| MousePheno | small upper incisors | 2.30e-04 | 7 | 47 | 2 | MP:0030081 | |
| MousePheno | short lower incisors | 2.30e-04 | 7 | 47 | 2 | MP:0030089 | |
| MousePheno | abnormal enamel rod pattern | 3.06e-04 | 8 | 47 | 2 | MP:0002649 | |
| MousePheno | abnormal zygomatic bone morphology | 3.47e-04 | 41 | 47 | 3 | MP:0005270 | |
| MousePheno | abnormal melanosome morphology | 4.28e-04 | 44 | 47 | 3 | MP:0005075 | |
| MousePheno | abnormal white adipose tissue physiology | 4.58e-04 | 45 | 47 | 3 | MP:0005670 | |
| MousePheno | adipose tissue phenotype | NCOR2 NCOA6 CLSTN3 RHBDF2 TLE4 PITX1 CRYBG1 TNS2 CHD2 ARHGEF11 LEF1 RNF43 ALG13 | 4.66e-04 | 1383 | 47 | 13 | MP:0005375 |
| MousePheno | decreased tooth number | 4.89e-04 | 46 | 47 | 3 | MP:0030608 | |
| MousePheno | abnormal tooth wear | 4.89e-04 | 10 | 47 | 2 | MP:0030458 | |
| MousePheno | vertebral transformation | 4.99e-04 | 110 | 47 | 4 | MP:0003036 | |
| MousePheno | abnormal incisor morphology | 4.99e-04 | 110 | 47 | 4 | MP:0005358 | |
| MousePheno | decreased spongiotrophoblast cell number | 5.97e-04 | 11 | 47 | 2 | MP:0030989 | |
| MousePheno | abnormal pilosebaceous unit morphology | 6.01e-04 | 205 | 47 | 5 | MP:0030572 | |
| MousePheno | abnormal adipose tissue amount | NCOR2 NCOA6 CLSTN3 TLE4 PITX1 CRYBG1 TNS2 CHD2 LEF1 RNF43 ALG13 | 7.10e-04 | 1077 | 47 | 11 | MP:0005452 |
| MousePheno | reduced enamel thickness | 7.15e-04 | 12 | 47 | 2 | MP:0002577 | |
| MousePheno | brittle teeth | 7.15e-04 | 12 | 47 | 2 | MP:0000126 | |
| MousePheno | increased lung tissue damping | 8.43e-04 | 13 | 47 | 2 | MP:0011047 | |
| MousePheno | abnormal gonial bone morphology | 8.43e-04 | 13 | 47 | 2 | MP:0008380 | |
| MousePheno | abnormal enamel mineralization | 8.43e-04 | 13 | 47 | 2 | MP:0030450 | |
| MousePheno | abnormal tooth number | 8.71e-04 | 56 | 47 | 3 | MP:0030611 | |
| MousePheno | short incisors | 9.81e-04 | 14 | 47 | 2 | MP:0004830 | |
| Domain | CSTF2_hinge | 8.21e-06 | 2 | 54 | 2 | IPR025742 | |
| Domain | Amelogenin | 8.21e-06 | 2 | 54 | 2 | SM00818 | |
| Domain | Amelogenin | 8.21e-06 | 2 | 54 | 2 | PF02948 | |
| Domain | CSTF2_hinge | 8.21e-06 | 2 | 54 | 2 | PF14327 | |
| Domain | Amelogenin | 8.21e-06 | 2 | 54 | 2 | IPR004116 | |
| Domain | CSTF_C | 8.21e-06 | 2 | 54 | 2 | PF14304 | |
| Domain | CSTF_C | 8.21e-06 | 2 | 54 | 2 | IPR026896 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 2.33e-05 | 20 | 40 | 3 | M497 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 2.33e-05 | 20 | 40 | 3 | MM15469 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.75e-05 | 62 | 40 | 4 | MM15426 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 3.74e-05 | 67 | 40 | 4 | M27694 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 7.35e-05 | 29 | 40 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 7.35e-05 | 29 | 40 | 3 | MM15444 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 9.10e-05 | 84 | 40 | 4 | M1008 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.58e-04 | 110 | 40 | 4 | M48259 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.38e-04 | 118 | 40 | 4 | MM15588 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 3.48e-04 | 10 | 40 | 2 | MM15156 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 6.47e-04 | 60 | 40 | 3 | M41830 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.99e-04 | 14 | 40 | 2 | M27402 | |
| Pubmed | Sonic hedgehog regulates growth and morphogenesis of the tooth. | 3.28e-08 | 21 | 55 | 4 | 11044393 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 FOXJ2 NCOR2 CHERP GSE1 RBM33 WDR33 GATA3 RNF216 CHD2 ONECUT1 TP53BP1 RNF111 | 3.58e-08 | 1203 | 55 | 13 | 29180619 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CASC3 CHERP EIF4ENIF1 RBM33 WDR33 HELZ2 CSTF2 CHD2 MEX3B CSTF2T ALG13 | 4.63e-08 | 807 | 55 | 11 | 22681889 |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 20816801 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 3.12e-07 | 9 | 55 | 3 | 17335794 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.15e-07 | 180 | 55 | 6 | 35198878 | |
| Pubmed | Sox2 and Lef-1 interact with Pitx2 to regulate incisor development and stem cell renewal. | 4.46e-07 | 10 | 55 | 3 | 27660324 | |
| Pubmed | Ectodermal Organ Development Is Regulated by a microRNA-26b-Lef-1-Wnt Signaling Axis. | 6.12e-07 | 11 | 55 | 3 | 32760291 | |
| Pubmed | Epithelial Cdc42 Deletion Induced Enamel Organ Defects and Cystogenesis. | 8.15e-07 | 12 | 55 | 3 | 29874522 | |
| Pubmed | FoxO6 regulates Hippo signaling and growth of the craniofacial complex. | 1.35e-06 | 14 | 55 | 3 | 30286078 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.62e-06 | 922 | 55 | 10 | 27609421 | |
| Pubmed | GATA3 is essential for separating patterning domains during facial morphogenesis. | 1.68e-06 | 15 | 55 | 3 | 34383890 | |
| Pubmed | NCOR2 NCOA6 EIF4ENIF1 GSE1 RBM33 WDR33 TLE4 PITX1 GATA3 CSTF2 RELA TP53BP1 | 1.88e-06 | 1429 | 55 | 12 | 35140242 | |
| Pubmed | 2.07e-06 | 16 | 55 | 3 | 21402782 | ||
| Pubmed | A family of splice variants of CstF-64 expressed in vertebrate nervous systems. | 2.46e-06 | 2 | 55 | 2 | 19284619 | |
| Pubmed | Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. | 2.46e-06 | 2 | 55 | 2 | 11406633 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12851394 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 18346915 | ||
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 2.46e-06 | 2 | 55 | 2 | 12773396 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 29337060 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8297387 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16284958 | ||
| Pubmed | Human and mouse amelogenin gene loci are on the sex chromosomes. | 2.46e-06 | 2 | 55 | 2 | 2737677 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 17029590 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19086270 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8988368 | ||
| Pubmed | Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale. | 2.46e-06 | 2 | 55 | 2 | 21825148 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12489164 | ||
| Pubmed | Amelogenin: a potential regulator of cementum-associated genes. | 2.46e-06 | 2 | 55 | 2 | 14653387 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 7489712 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25449314 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 36585836 | ||
| Pubmed | Isolation and characterization of a mouse amelogenin expressed in Escherichia coli. | 2.46e-06 | 2 | 55 | 2 | 8062146 | |
| Pubmed | Transgenic mice that express normal and mutated amelogenins. | 2.46e-06 | 2 | 55 | 2 | 17384027 | |
| Pubmed | Alternative splicing of the mouse amelogenin primary RNA transcript. | 2.46e-06 | 2 | 55 | 2 | 7820782 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 26709694 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 7782077 | ||
| Pubmed | Comparison of body weight and gene expression in amelogenin null and wild-type mice. | 2.46e-06 | 2 | 55 | 2 | 16674684 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 27896287 | ||
| Pubmed | Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro. | 2.46e-06 | 2 | 55 | 2 | 20404336 | |
| Pubmed | Maintenance of amelogenin gene expression by transformed epithelial cells of mouse enamel organ. | 2.46e-06 | 2 | 55 | 2 | 1444889 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 18394981 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23896516 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 34281250 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 1427830 | ||
| Pubmed | Transgene animal model for protein expression and accumulation into forming enamel. | 2.46e-06 | 2 | 55 | 2 | 11063035 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10200911 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 14681198 | ||
| Pubmed | Truncated amelogenin and LRAP transgenes improve Amelx null mouse enamel. | 2.46e-06 | 2 | 55 | 2 | 26607574 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 2004775 | ||
| Pubmed | Loss of biological control of enamel mineralization in amelogenin-phosphorylation-deficient mice. | 2.46e-06 | 2 | 55 | 2 | 35219810 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 2689082 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16707492 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21984897 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24067439 | ||
| Pubmed | The murine amelogenin promoter: developmentally regulated expression in transgenic animals. | 2.46e-06 | 2 | 55 | 2 | 9084642 | |
| Pubmed | Cryogenic transmission electron microscopy study of amelogenin self-assembly at different pH. | 2.46e-06 | 2 | 55 | 2 | 21597263 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 23948316 | ||
| Pubmed | Lymphoid enhancer factor interacts with GATA-3 and controls its function in T helper type 2 cells. | 2.46e-06 | 2 | 55 | 2 | 18445004 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8392462 | ||
| Pubmed | Amelogenins as potential buffers during secretory-stage amelogenesis. | 2.46e-06 | 2 | 55 | 2 | 25535204 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20923441 | ||
| Pubmed | Model system for evaluation of alternative splicing: exon skipping. | 2.46e-06 | 2 | 55 | 2 | 11879574 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 9878259 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 11852235 | ||
| Pubmed | Amelogenin genes and sexual dimorphism of teeth in humans and mice. | 2.46e-06 | 2 | 55 | 2 | 1463023 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8179220 | ||
| Pubmed | Phosphorylation and ionic strength alter the LRAP-HAP interface in the N-terminus. | 2.46e-06 | 2 | 55 | 2 | 23477367 | |
| Pubmed | Protein interactions during assembly of the enamel organic extracellular matrix. | 2.46e-06 | 2 | 55 | 2 | 9041053 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 36569763 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25792521 | ||
| Pubmed | The leucine-rich amelogenin peptide alters the amelogenin null enamel phenotype. | 2.46e-06 | 2 | 55 | 2 | 18701811 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12667550 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 3253061 | ||
| Pubmed | Putative signaling action of amelogenin utilizes the Wnt/beta-catenin pathway. | 2.46e-06 | 2 | 55 | 2 | 19462488 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8618899 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20067920 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31621902 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16293627 | ||
| Pubmed | Leucine rich amelogenin peptide alters ameloblast differentiation in vivo. | 2.46e-06 | 2 | 55 | 2 | 23747796 | |
| Pubmed | Evolution in tooth developmental biology: of morphology and molecules. | 2.46e-06 | 2 | 55 | 2 | 8769659 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21547453 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 1445358 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 11877393 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16207706 | ||
| Pubmed | Partial rescue of the amelogenin null dental enamel phenotype. | 2.46e-06 | 2 | 55 | 2 | 18390542 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21540557 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31239344 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 19097165 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20304108 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24362885 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 15647828 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 4015654 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25885796 | ||
| Pubmed | Structural variation of the pseudoautosomal region between and within inbred mouse strains. | 2.46e-06 | 2 | 55 | 2 | 8552598 | |
| Pubmed | The amelogenin C-terminus is required for enamel development. | 2.46e-06 | 2 | 55 | 2 | 20042744 | |
| Pubmed | Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice. | 2.46e-06 | 2 | 55 | 2 | 34780561 | |
| Pubmed | Comparison of upstream regions of X- and Y-chromosomal amelogenin genes. | 2.46e-06 | 2 | 55 | 2 | 9714776 | |
| Pubmed | Overlapping and distinct functions of CstF64 and CstF64τ in mammalian mRNA 3' processing. | 2.46e-06 | 2 | 55 | 2 | 24149845 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 31919099 | ||
| Interaction | ALG13 interactions | 1.29e-09 | 183 | 54 | 9 | int:ALG13 | |
| Interaction | SMG7 interactions | NCOR2 ZSWIM8 NCOA6 EIF4ENIF1 GSE1 RBM33 TLE4 RNF43 MEX3B ALG13 | 1.11e-08 | 319 | 54 | 10 | int:SMG7 |
| Interaction | TLE3 interactions | 6.31e-07 | 376 | 54 | 9 | int:TLE3 | |
| Interaction | RBMS2 interactions | 4.60e-06 | 251 | 54 | 7 | int:RBMS2 | |
| Interaction | PPARA interactions | 4.71e-06 | 92 | 54 | 5 | int:PPARA | |
| Interaction | STH interactions | 1.44e-05 | 18 | 54 | 3 | int:STH | |
| Interaction | SP7 interactions | 1.60e-05 | 304 | 54 | 7 | int:SP7 | |
| Interaction | FAM168B interactions | 1.75e-05 | 58 | 54 | 4 | int:FAM168B | |
| Interaction | R3HDM2 interactions | 2.45e-05 | 129 | 54 | 5 | int:R3HDM2 | |
| Interaction | DTX2 interactions | 2.71e-05 | 330 | 54 | 7 | int:DTX2 | |
| Interaction | TNIP2 interactions | CASC3 NCOR2 CHERP WDR33 TLE4 SCAPER CSTF2 NDFIP2 RELA LEF1 CSTF2T | 3.65e-05 | 952 | 54 | 11 | int:TNIP2 |
| Interaction | ANKRD10 interactions | 4.01e-05 | 25 | 54 | 3 | int:ANKRD10 | |
| Interaction | DAZL interactions | 4.28e-05 | 145 | 54 | 5 | int:DAZL | |
| Interaction | LARP4B interactions | 4.29e-05 | 240 | 54 | 6 | int:LARP4B | |
| Interaction | AKAP8L interactions | 4.29e-05 | 240 | 54 | 6 | int:AKAP8L | |
| Interaction | EYA4 interactions | 4.60e-05 | 243 | 54 | 6 | int:EYA4 | |
| Interaction | TSC1 interactions | 5.23e-05 | 366 | 54 | 7 | int:TSC1 | |
| Interaction | CPEB4 interactions | 6.07e-05 | 156 | 54 | 5 | int:CPEB4 | |
| Interaction | RNF4 interactions | SHANK1 FOXJ2 NCOR2 CHERP GSE1 RBM33 WDR33 GATA3 RNF216 CHD2 ONECUT1 TP53BP1 RNF111 | 6.84e-05 | 1412 | 54 | 13 | int:RNF4 |
| Interaction | NCOR2 interactions | 7.28e-05 | 264 | 54 | 6 | int:NCOR2 | |
| Interaction | R3HDM1 interactions | 7.58e-05 | 84 | 54 | 4 | int:R3HDM1 | |
| Interaction | ASB3 interactions | 7.58e-05 | 84 | 54 | 4 | int:ASB3 | |
| Interaction | TNRC6A interactions | 1.01e-04 | 280 | 54 | 6 | int:TNRC6A | |
| Interaction | TOP3B interactions | VWA5B2 SEMA4F NCOR2 NCOA6 EIF4ENIF1 RHBDF2 RBM33 PITX1 HELZ2 ARHGEF11 RNF43 MEX3B TP53BP1 | 1.03e-04 | 1470 | 54 | 13 | int:TOP3B |
| Interaction | PAPOLA interactions | 1.08e-04 | 92 | 54 | 4 | int:PAPOLA | |
| Interaction | FOXI1 interactions | 1.08e-04 | 92 | 54 | 4 | int:FOXI1 | |
| Interaction | TLX3 interactions | 1.24e-04 | 291 | 54 | 6 | int:TLX3 | |
| Interaction | MAPK3 interactions | 1.25e-04 | 421 | 54 | 7 | int:MAPK3 | |
| Interaction | NUP35 interactions | 1.31e-04 | 424 | 54 | 7 | int:NUP35 | |
| Interaction | SEC16A interactions | 1.35e-04 | 426 | 54 | 7 | int:SEC16A | |
| Interaction | FUBP3 interactions | 1.39e-04 | 297 | 54 | 6 | int:FUBP3 | |
| Interaction | C1orf94 interactions | 1.67e-04 | 103 | 54 | 4 | int:C1orf94 | |
| Interaction | TLE5 interactions | 1.72e-04 | 443 | 54 | 7 | int:TLE5 | |
| Interaction | CREBBP interactions | 1.81e-04 | 599 | 54 | 8 | int:CREBBP | |
| Interaction | GATA2 interactions | 1.91e-04 | 199 | 54 | 5 | int:GATA2 | |
| Interaction | PCF11 interactions | 2.23e-04 | 111 | 54 | 4 | int:PCF11 | |
| Interaction | BAG2 interactions | 2.34e-04 | 622 | 54 | 8 | int:BAG2 | |
| Interaction | TBR1 interactions | 2.39e-04 | 113 | 54 | 4 | int:TBR1 | |
| Interaction | NFIC interactions | 2.45e-04 | 210 | 54 | 5 | int:NFIC | |
| Interaction | USP54 interactions | 2.56e-04 | 212 | 54 | 5 | int:USP54 | |
| Interaction | TLE1 interactions | 2.61e-04 | 213 | 54 | 5 | int:TLE1 | |
| Interaction | TBXT interactions | 2.64e-04 | 116 | 54 | 4 | int:TBXT | |
| Interaction | APBA2 interactions | 2.89e-04 | 48 | 54 | 3 | int:APBA2 | |
| Interaction | PLSCR3 interactions | 2.89e-04 | 48 | 54 | 3 | int:PLSCR3 | |
| Interaction | UFSP1 interactions | 3.07e-04 | 49 | 54 | 3 | int:UFSP1 | |
| Interaction | PAPOLB interactions | 3.13e-04 | 10 | 54 | 2 | int:PAPOLB | |
| Interaction | NCOA3 interactions | 3.29e-04 | 224 | 54 | 5 | int:NCOA3 | |
| Interaction | RCOR1 interactions | 3.33e-04 | 494 | 54 | 7 | int:RCOR1 | |
| Interaction | MCRIP2 interactions | 3.46e-04 | 51 | 54 | 3 | int:MCRIP2 | |
| Interaction | TGFBR3 interactions | 3.66e-04 | 52 | 54 | 3 | int:TGFBR3 | |
| Interaction | TRIP6 interactions | 3.79e-04 | 358 | 54 | 6 | int:TRIP6 | |
| Interaction | PAX9 interactions | 4.07e-04 | 130 | 54 | 4 | int:PAX9 | |
| Interaction | ABCA1 interactions | 4.09e-04 | 54 | 54 | 3 | int:ABCA1 | |
| Interaction | HGS interactions | 4.69e-04 | 523 | 54 | 7 | int:HGS | |
| Interaction | LASP1 interactions | 5.15e-04 | 247 | 54 | 5 | int:LASP1 | |
| Interaction | FMR1 interactions | 5.43e-04 | 536 | 54 | 7 | int:FMR1 | |
| Interaction | MKRN2 interactions | 5.57e-04 | 385 | 54 | 6 | int:MKRN2 | |
| Interaction | FBXO22 interactions | 5.68e-04 | 540 | 54 | 7 | int:FBXO22 | |
| Interaction | NCOA6 interactions | 6.15e-04 | 145 | 54 | 4 | int:NCOA6 | |
| Interaction | HELZ interactions | 6.16e-04 | 257 | 54 | 5 | int:HELZ | |
| Interaction | EWSR1 interactions | CASC3 NCOA6 CHERP EIF4ENIF1 RBM33 PITX1 CSTF2 CSTF2T TP53BP1 | 6.20e-04 | 906 | 54 | 9 | int:EWSR1 |
| Interaction | XRN1 interactions | 6.27e-04 | 258 | 54 | 5 | int:XRN1 | |
| Interaction | PAIP2 interactions | 6.45e-04 | 63 | 54 | 3 | int:PAIP2 | |
| Interaction | SMO interactions | 6.45e-04 | 63 | 54 | 3 | int:SMO | |
| Interaction | C10orf55 interactions | 7.06e-04 | 65 | 54 | 3 | int:C10orf55 | |
| Interaction | PRRC2B interactions | 7.08e-04 | 265 | 54 | 5 | int:PRRC2B | |
| Interaction | KDM1A interactions | 8.13e-04 | 941 | 54 | 9 | int:KDM1A | |
| Interaction | NFE2L2 interactions | 8.68e-04 | 159 | 54 | 4 | int:NFE2L2 | |
| Interaction | UBE2D3 interactions | 9.50e-04 | 283 | 54 | 5 | int:UBE2D3 | |
| Interaction | EGR1 interactions | 9.52e-04 | 72 | 54 | 3 | int:EGR1 | |
| GeneFamily | Ring finger proteins | 2.57e-03 | 275 | 38 | 4 | 58 | |
| GeneFamily | Tudor domain containing | 2.73e-03 | 37 | 38 | 2 | 780 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.48e-03 | 66 | 38 | 2 | 722 | |
| GeneFamily | RNA binding motif containing | 1.00e-02 | 213 | 38 | 3 | 725 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.77e-06 | 492 | 54 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| ToppCell | TCGA-Adrenal|World / Sample_Type by Project: Shred V9 | 3.11e-05 | 145 | 55 | 4 | 522ad2bc90b8ec326fcbc7b2250b09566efeeca2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 147 | 55 | 4 | 9566398275cad79223db90ffe640830acf2db864 | |
| ToppCell | URO-Lymphocyte-T_NK-Treg|URO / Disease, Lineage and Cell Type | 3.93e-05 | 154 | 55 | 4 | 73fe0e26088a1b012902cc062ffbb3e4d2ff09f9 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-05 | 157 | 55 | 4 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 4.56e-05 | 160 | 55 | 4 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefm_(MGE-derived_cortical_interneurons--basket_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 56 | 55 | 3 | ac776a6e8d0b5596dc492a05235e518cbfc7b5ed | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefm_(MGE-derived_cortical_interneurons--basket_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 56 | 55 | 3 | 0417516b9241a756fb2bcd611691c675ca98030d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.39e-05 | 167 | 55 | 4 | 4b6853efefea5178280ba7c31facda0fbd1cc469 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 172 | 55 | 4 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 175 | 55 | 4 | 84d91843b34504636d5af6bda9930031409a1627 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 175 | 55 | 4 | 2368aa8318ab83e0e0fd539a17264f9e1d755cf1 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Tac1_(Interneuron,_Basket_1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.16e-05 | 65 | 55 | 3 | 25d2f56f6cd982a227772f8a3b453cdcc8516a47 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Tac1_(Interneuron,_Basket_1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.16e-05 | 65 | 55 | 3 | d7d571be0662967e6d8d934e45f928a2f9e1c06a | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.52e-05 | 182 | 55 | 4 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.52e-05 | 182 | 55 | 4 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.52e-05 | 182 | 55 | 4 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.68e-05 | 183 | 55 | 4 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.52e-05 | 188 | 55 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-05 | 188 | 55 | 4 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-05 | 189 | 55 | 4 | 1a891ae8517086fcf6443660976aef6413fa79ae | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.88e-05 | 190 | 55 | 4 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-05 | 190 | 55 | 4 | d83fdc352ebb0c2f2a7c2138bf6e3b7a8ce83a6a | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.25e-05 | 192 | 55 | 4 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 1.00e-04 | 196 | 55 | 4 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | 2f2e5a5e1cb00b9e51c1a9f86d34ac65cb8b3999 | |
| Computational | Signaling. | 1.69e-04 | 374 | 35 | 7 | MODULE_94 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 6.90e-06 | 196 | 54 | 6 | 3724_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 7.11e-06 | 197 | 54 | 6 | 5415_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 7.11e-06 | 197 | 54 | 6 | 4192_UP | |
| Drug | ganoine | 1.65e-05 | 3 | 54 | 2 | CID000131592 | |
| Drug | HBGG | 1.88e-05 | 22 | 54 | 3 | CID000125044 | |
| Disease | amelogenesis imperfecta type 1E (implicated_via_orthology) | 3.29e-06 | 2 | 54 | 2 | DOID:0110058 (implicated_via_orthology) | |
| Disease | autosomal dominant hypocalcemia (biomarker_via_orthology) | 1.97e-05 | 4 | 54 | 2 | DOID:0090109 (biomarker_via_orthology) | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.75e-04 | 59 | 54 | 3 | EFO_0022248 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.84e-04 | 60 | 54 | 3 | EFO_0022330 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 6.52e-04 | 215 | 54 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | epilepsy (biomarker_via_orthology) | 6.75e-04 | 21 | 54 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 7.10e-04 | 220 | 54 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.59e-04 | 224 | 54 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 7.72e-04 | 225 | 54 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 8.25e-04 | 229 | 54 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.03e-03 | 243 | 54 | 4 | EFO_0004612, EFO_0020944 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.21e-03 | 28 | 54 | 2 | DOID:8634 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement | 1.32e-03 | 260 | 54 | 4 | EFO_0008317 | |
| Disease | Epileptic encephalopathy | 1.38e-03 | 30 | 54 | 2 | C0543888 | |
| Disease | eosinophil count | 1.40e-03 | 1488 | 54 | 9 | EFO_0004842 | |
| Disease | Colorectal Carcinoma | 1.74e-03 | 702 | 54 | 6 | C0009402 | |
| Disease | Colonic Neoplasms | 2.74e-03 | 152 | 54 | 3 | C0009375 | |
| Disease | Breast Carcinoma | 3.00e-03 | 538 | 54 | 5 | C0678222 | |
| Disease | Malignant tumor of colon | 3.11e-03 | 159 | 54 | 3 | C0007102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGAAFAMPLPPHPGH | 11 | Q99217 | |
| VGAAFAMPLPPHPGH | 11 | Q99218 | |
| LPPRLQHSMHYGHDP | 611 | Q9NP73 | |
| HRGHQPPPEMAGHSL | 821 | Q9BQT9 | |
| GSMAQLPHHHVPEPA | 441 | A1IGU5 | |
| PGSLPPLHPSAMHLH | 286 | Q14687 | |
| ATRHPGAAPMPVHPP | 1081 | O15085 | |
| MHGPTGHCPHPRVLP | 311 | Q8IY22 | |
| GPHRDHPLGGVHPME | 751 | Q9BZ11 | |
| MHHVPGHESRGPPPH | 356 | P33240 | |
| PFVLMHPKPHDHIPL | 341 | P32121 | |
| PVQHPHHPSPPQGMH | 346 | Q96EV2 | |
| RFSHHMIPGPPGPHT | 241 | Q9UJU2 | |
| MGRAIPPERHSPHHL | 1331 | Q9Y618 | |
| HAAHHVMGPPLRPDP | 291 | Q14117 | |
| MPMPSRDGGLHPRHH | 1 | Q8TDN1 | |
| HPHNPLLHGGRKMPD | 221 | Q8WU58 | |
| MVPINGLPPHHPHAH | 241 | Q9UBC0 | |
| PHPAHPMLHEPFLFG | 16 | O96004 | |
| AHHMVPRPSVPPPGA | 546 | Q9P0K8 | |
| MIPHAGGHPLDTPHL | 11 | Q02509 | |
| HPSGSLAPPHHPMQP | 231 | Q14686 | |
| RKPDPEPGRMDHHQP | 86 | Q9NV92 | |
| PMHPPSSLSFGPHHP | 421 | P23771 | |
| PGMNLPHPGLHPHQT | 576 | O15234 | |
| PLECPALPMIHNGHH | 151 | P20023 | |
| GDFPAEMGPPHHHPG | 576 | Q8IWX8 | |
| PHLPASHGPQMHGHP | 1606 | O14647 | |
| PRPLIHHPCMHPDML | 161 | Q86WZ0 | |
| HHPCMHPDMLGRPPS | 166 | Q86WZ0 | |
| GPVAVPMSLGHAPPH | 161 | P05111 | |
| GPPMHHASGHDTRGP | 361 | Q9H0L4 | |
| PAPHFAMPPIHEDHL | 726 | Q9Y4K1 | |
| VPPHPRHYPLMFCHV | 771 | Q9BYK8 | |
| EPARPPGHGIHMHEK | 516 | Q9BY12 | |
| HSPPHPVAVAAPGMP | 136 | P56715 | |
| LSPPLHMAPGAGEHH | 441 | Q6ZN04 | |
| GPLHVPMNPEPAGSH | 196 | P43354 | |
| PPPPHDMGPAFHLAR | 21 | P78337 | |
| HPLMDRPVFPADGHP | 411 | O95754 | |
| PGMGPRHHRFPRAAH | 381 | Q68DV7 | |
| PREPVSPAGPHHHRP | 1406 | Q6ZUB1 | |
| EHNLPMHFGPQPRHR | 851 | Q9NWF9 | |
| HHAHPPHPPEMETGG | 1016 | Q9Y566 | |
| HVPMVRPAHQLHPGL | 816 | Q9NRA8 | |
| PIHAANLHIMHPHPP | 211 | Q6ZVT6 | |
| AHECMPHHPGSPSEP | 71 | Q8TEF2 | |
| MMQHPTRAHERPPPH | 761 | Q6ZNA4 | |
| TRAHERPPPHPHRMH | 766 | Q6ZNA4 | |
| RPPPHPHRMHPNYGH | 771 | Q6ZNA4 | |
| PHHHMRVPAIPPNLT | 426 | Q04727 | |
| DMPQPPHGHVLHRHM | 1226 | Q12888 | |
| AHPAHPMPHMPRPAV | 1526 | A7E2V4 | |
| HPSEPHQPHLMLEGG | 271 | Q8N398 | |
| GPPNHHMGPMSERRH | 961 | Q9C0J8 | |
| FRHPEEMDRPHAPHP | 196 | Q6PJF5 | |
| PPHRPHPHELVGKDC | 81 | Q04206 | |
| PLLLPACGHHHAPMP | 736 | Q63HR2 |